-
-
Concerns about asymptomatic sexually transmitted infections in women at high risk for disease might deter clinicians from same-day placement of intrauterine devices (IUDs). However, results from two studies presented at a national meeting indicate such delays are unnecessary.
-
The Centers for Disease Control and Prevention and the Office of Population Affairs of the U.S. Department of Health and Human Services have issued new guidance to improve family planning services.
-
Results of a new genetic analysis indicate that 69% of healthy American adults are infected with one or more of 109 strains of the human papillomavirus (HPV).
-
Postpartum placement of long-acting reversible contraception (LARC) might be an effective way to address unplanned pregnancies in adolescents. Efficacy is key in preventing rapid repeat pregnancy; 20% of adolescent mothers give birth again within two years.
-
The Centers for Disease Control and Prevention (CDC) has issued clinical guidance for use of anti-HIV drugs in uninfected patients who are at substantial risk of infection.
-
Eleven research teams have received funding from the Bill and Melinda Gates Foundation of Seattle to pursue new condom designs that could help increase condom use by improving sexual sensation and other aspects of user experience.
-
When it comes to choosing an effective contraceptive, many women look to the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo-Provera Pfizer; New York City, Medroxyprogesterone Acetate Injection, Teva Pharmaceuticals USA; North Wales, PA), say respondents to the 2008 Contraceptive Technology Update Contraception Survey.
-
Where do generic oral contraceptives fit in your facility's formulary? About 70% of participants in the 2008 Contraceptive Technology Update Contraception Survey say their facilities have increased the use of generic oral contraceptives due to budget constraints, up 5% from 2007's statistic.
-
While new methods are gaining favor with women, oral contraceptives (OCs) continue to be a popular method of birth control, say respondents to the 2008 Contraceptive Technology Update Contraception Survey. About 42% of survey participants report over half of their patients leave the office with an OC prescription in hand.